KWILP
EDIT icon

Kiwi Wealth Investments Limited Partnership’s Editas Medicine EDIT Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,260
Closed -$315K – 89
2023
Q2 		$315K Hold
38,260
– – 0.02% 186
2023
Q1 		$277K Sell
38,260
-32,185
-46% -$286K 0.02% 169
2022
Q4 		$625K Buy
+70,445
New +$773K 0.04% 179

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's EDIT Position: Q3 2023 in Review

Kiwi Wealth Investments Limited Partnership sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 38,260 shares — an estimated $315K sold.

Kiwi Wealth Investments Limited Partnership first reported a position in EDIT in Q4 2022 and held it in 3 quarters. The position peaked at $625K in Q4 2022. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 38,260 Editas Medicine shares in Q3 2023, an estimated $315K.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Editas Medicine in Q4 2022 and held it in 3 quarters.
  • Kiwi Wealth Investments Limited Partnership's Editas Medicine position peaked at $625K in Q4 2022.
  • 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2023, filed 14 Nov 2023.